IRCT20220212054005N1已完成3 期
The radioprotective effect of oral nanocurcumin in thyroid cancer patients after high dose radioactive iodine administration by examining the amount of inflamatory factor TNFa by ELISA test in patients blood serum
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 24 years 至 79 years（—）
- 性别
- All
入选标准
- •patient informed satisfaction
- •dose received by patients should be between 150 to 200 mci
- •patients should be 24 to 79 years old
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Effect of nano-curcumin on radiotherapy-induced skin reaction in breast cancer patients: a randomized, triple-blind, placebo-controlled trialIRCT20200513047427N1Kashan University of Medical Sciences42
尚未招募
3 期
Assessment of the effect of nano-curcumin oral intake on clinical signs and serum IL-6 levels in patients with ischemic stroke: Double-blind Clinical TrialIRCT20091108002680N3Rasht University of Medical Sciences40
已完成
不适用
The protective effects of nanocurcumin against unpleasant effects of radiotherapyIRCT2016030917006N2Vice chancellor for research, Mashhad University of Medical Sciences. (Primary sponsor)90
已完成
不适用
Effect of oral nanocurcumin in patients with Behcet's disease.Behcet's diseaseBehcet's disease.M35.2IRCT20160422027520N12Connective Tissue Diseases Research Center36
已完成
2 期
Effect of Nano-Curcumin On Neoadjuvant Chemotherapy of Bladder Cancer PatientsBladder Cancer.Malignant neoplasm of bladderIRCT20180226038875N1Shahid Beheshti University of Medical Sciences24